Focused Large Cap Value Fund
American Century Capital Portfolios, Inc. · 8 share classes
Fund classification
Classified from what the fund holds · as of 2026 Q2
Focused Large Cap Value Fund is an actively managed U.S. equity fund. 0% of ALVIX’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 87% of the fund’s equity).
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2025 Q3
The fund seeks long-term capital growth.
The fund invests at least 80% of assets in large-capitalization stocks within the Russell 1000 Index range, selecting companies whose stock prices the managers believe undervalue the business; stocks are held until price reaches estimated fair value and then sold. The fund typically holds 30–50 stocks and may include foreign securities meeting the same valuation criteria. Because the fund concentrates in a limited number of holdings, performance depends heavily on the success of those individual picks.
| Share class | Gross | Net |
|---|---|---|
| ALVIX | 0.84% | 0.84% |
| ALPAX | 1.09% | 1.09% |
| ALVSX | 0.64% | 0.64% |
| ALPCX | 1.84% | 1.84% |
| ALVRX | 1.34% | 1.34% |
| ALVDX | 0.49% | 0.49% |
| ALVGX | 0.64% | 0.64% |
| ACFLX | 0.49% | 0.01% |
Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.
Portfolio turnover 51.00% · as of 2025 Q3
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 98.57% |
| Cash & short-term | 1.23% |
| Derivatives | 0.01% |
Derivatives are shown at market value, not notional exposure.
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Financials | 22.1% |
| Health Care | 14.8% |
| Information Technology | 12.2% |
| Industrials | 10.6% |
| 9 smaller | 40.3% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Portfolio growth profile
How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2
Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +21.74% | +41.46% | +57.55% | 11.30% | -7.24% | |
| +21.46% | +40.43% | +55.60% | 11.43% | -7.31% | |
| +22.06% | +42.39% | +59.19% | 11.33% | -7.19% | |
| +20.51% | +37.36% | +49.90% | 11.41% | -7.48% | |
| +21.12% | +39.30% | +53.70% | 11.34% | -7.35% | |
| +22.14% | +42.92% | +60.28% | 11.47% | -7.15% | |
| +22.04% | +42.34% | +59.27% | 11.42% | -7.18% | |
| +22.66% | +44.88% | — | 11.38% | -7.13% |
These classes hold the same portfolio, so the 7.52pp spread over 3 years is the cost difference between them — roughly 2.51pp a year — not a difference in what they own.
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| MRSH | Marsh & McLennan Cos IncMRSH | 3.98% | $166.67 | $116.84M | 701.0K |
| MSFT | Microsoft CorpMSFT | 3.74% | $373.02 | $109.63M | 293.9K |
| DUK | Duke Energy CorpDUK | 3.56% | $126.58 | $104.38M | 824.6K |
| BRK/B | Berkshire Hathaway IncBRK/B | 3.42% | $500.39 | $100.32M | 200.5K |
| JNJ | Johnson & JohnsonJNJ | 3.22% | $253.97 | $94.52M | 372.2K |
| AMZN | Amazon.com IncAMZN | 3.21% | $238.34 | $94.14M | 395.0K |
| JPM | JPMorgan Chase & CoJPM | 3.21% | $327.33 | $94.07M | 287.4K |
| BDX | Becton Dickinson & CoBDX | 3.16% | $151.33 | $92.72M | 612.7K |
| — | Enterprise Products Partners LP | 2.75% | $36.76 | $80.65M | 2.2M |
| BLK | Blackrock IncBLK | 2.70% | $961.56 | $79.25M | 82.4K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 32.96% of net assets, top 25 65.91%, across 53 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free